These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36209926)

  • 1. Anti-inflammatory effects of ellagic acid and vanillic acid against quinolinic acid-induced rat model of Huntington's disease by targeting IKK-NF-κB pathway.
    Bains M; Kaur J; Akhtar A; Kuhad A; Sah SP
    Eur J Pharmacol; 2022 Nov; 934():175316. PubMed ID: 36209926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: Possible neurotransmitters modulation.
    Gill JS; Jamwal S; Kumar P; Deshmukh R
    Pharmacol Rep; 2017 Apr; 69(2):306-313. PubMed ID: 28178592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences.
    Kumar A; Chaudhary T; Mishra J
    Eur J Pharmacol; 2013 Nov; 720(1-3):16-28. PubMed ID: 24211676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington's disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway.
    Saroj P; Bansal Y; Singh R; Akhtar A; Sodhi RK; Bishnoi M; Sah SP; Kuhad A
    Inflammopharmacology; 2021 Apr; 29(2):499-511. PubMed ID: 33517508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid-induced neurotoxicity: Possible role of PPAR-γ, Bax/Bcl-2, and caspase-3.
    Cui J; Wang G; Kandhare AD; Mukherjee-Kandhare AA; Bodhankar SL
    Food Chem Toxicol; 2018 Nov; 121():95-108. PubMed ID: 30130594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA and non-NMDA receptor-stimulated IkappaB-alpha degradation: differential effects of the caspase-3 inhibitor DEVD.CHO, ethanol and free radical scavenger OPC-14117.
    Nakai M; Qin Z; Wang Y; Chase TN
    Brain Res; 2000 Mar; 859(2):207-16. PubMed ID: 10719066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats.
    Kalonia H; Kumar A
    Life Sci; 2011 Apr; 88(17-18):784-91. PubMed ID: 21362433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.
    Kumar P; Kalonia H; Kumar A
    Br J Pharmacol; 2011 Sep; 164(2b):644-54. PubMed ID: 21486276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of mitochondrial NAD(+)/FAD(+)-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: implications in Huntington's disease.
    Mishra J; Kumar A
    Pharmacol Rep; 2014 Dec; 66(6):1148-55. PubMed ID: 25443748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
    Umesalma S; Sudhandiran G
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):650-5. PubMed ID: 20406206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
    Colle D; Hartwig JM; Soares FA; Farina M
    Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats.
    Kalonia H; Kumar P; Kumar A; Nehru B
    Neuroscience; 2010 Nov; 171(1):284-99. PubMed ID: 20813166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala
    Verma MK; Goel R; Nandakumar K; Nemmani KVS
    Eur J Pharmacol; 2018 Jun; 828():31-41. PubMed ID: 29577894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
    Ryu JK; Kim SU; McLarnon JG
    Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effect of Spermidine Against Excitotoxic Neuronal Death Induced by Quinolinic Acid in Rats: Possible Neurotransmitters and Neuroinflammatory Mechanism.
    Jamwal S; Singh S; Kaur N; Kumar P
    Neurotox Res; 2015 Aug; 28(2):171-84. PubMed ID: 26078029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin L plays a role in quinolinic acid-induced NF-Κb activation and excitotoxicity in rat striatal neurons.
    Wang YR; Qin S; Han R; Wu JC; Liang ZQ; Qin ZH; Wang Y
    PLoS One; 2013; 8(9):e75702. PubMed ID: 24073275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-shogaol against 3-Nitropropionic acid-induced Huntington's disease in rodents: Based on molecular docking/targeting pro-inflammatory cytokines/NF-κB-BDNF-Nrf2 pathway.
    Jambi EJ; Alamri A; Afzal M; Al-Abbasi FA; Al-Qahtani SD; Almalki NAR; Bawadood AS; Alzarea SI; Sayyed N; Kazmi I
    PLoS One; 2024; 19(7):e0305358. PubMed ID: 39008492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone synergizes the neuroprotective effects of valproic acid against quinolinic acid-induced neurotoxicity in rats: targeting PPARγ and HDAC pathways.
    Mishra J; Chaudhary T; Kumar A
    Neurotox Res; 2014 Aug; 26(2):130-51. PubMed ID: 24566814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease.
    Sharma P; Kumar M; Bansal N
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1917-1928. PubMed ID: 34061228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperoside attenuates neuroinflammation, cognitive impairment and oxidative stress via suppressing TNF-α/NF-κB/caspase-3 signaling in type 2 diabetes rats.
    Chen X; Famurewa AC; Tang J; Olatunde OO; Olatunji OJ
    Nutr Neurosci; 2022 Aug; 25(8):1774-1784. PubMed ID: 33722183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.